Inactive Instrument

SYNTH MR Stock Swiss Exchange

Equities

SE0005454865

Advanced Medical Equipment & Technology

End-of-day quote Swiss Exchange
- SEK - Intraday chart for SYNTH MR

Financials

Sales 2024 * 76.22M 7.22M 9.89M Sales 2025 * 99.19M 9.4M 12.87M Capitalization 1.15B 109M 150M
Net income 2024 * 4M 379K 519K Net income 2025 * 14M 1.33M 1.82M EV / Sales 2024 * 15.1 x
Net cash position 2024 * 6.82M 646K 885K Net cash position 2025 * 6.81M 645K 884K EV / Sales 2025 * 11.6 x
P/E ratio 2024 *
277 x
P/E ratio 2025 *
82.7 x
Employees -
Yield 2024 *
-
Yield 2025 *
0.54%
Free-Float 42.6%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 55 19-08-31
Founder 51 07-02-15
Director of Finance/CFO 50 21-03-31
Members of the board TitleAgeSince
Director/Board Member 68 12-12-31
Director/Board Member 60 20-12-31
Founder 51 07-02-15
More insiders
SyntheticMR AB (publ) is a Sweden-based company that develops and markets software solutions for Magnetic Resonance Imaging (MRI). The Company provides SyMRI, which measures the absolute properties of the brain and delivers adjustable contrast images, automatic biomarker segmentation and quantitative data in a single MR scan. The SyMRI product is available in different packages. SyMRI IMAGE provides fast MRI workflows, allowing high patient throughput. SyMRI NEURO enables automatic segmentation of brain tissue, providing objective decision support. SyMRI Research Edition includes exportable SyMaps, parametric common contrast weighted images and maps of the brain, allowing the investigation to be taken even further. SyMRI is a registered trademark in Europe and in the USA.
More about the company